BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8842702)

  • 1. Characterization of lipophosphoglycan from a ricin-resistant mutant of Leishmania major.
    Opat A; Ng K; Currie G; Handman E; Bacic A
    Glycobiology; 1996 Jun; 6(4):387-97. PubMed ID: 8842702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a ricin-resistant mutant of Leishmania donovani that expresses lipophosphoglycan.
    Phillips MR; Turco SJ
    Glycobiology; 2015 Apr; 25(4):428-37. PubMed ID: 25472443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of lipophosphoglycan from Leishmania major: characterization of (beta 1-3)-galactosyltransferase(s).
    Ng K; Handman E; Bacic A
    Glycobiology; 1994 Dec; 4(6):845-53. PubMed ID: 7734847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of Leishmania lipophosphoglycan: inter- and intra-specific polymorphism in Old World species.
    McConville MJ; Schnur LF; Jaffe C; Schneider P
    Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):807-18. PubMed ID: 7575413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the lipophosphoglycan from Leishmania major.
    McConville MJ; Thomas-Oates JE; Ferguson MA; Homans SW
    J Biol Chem; 1990 Nov; 265(32):19611-23. PubMed ID: 2246247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophosphoglycan expression and virulence in ricin-resistant variants of Leishmania major.
    Elhay M; Kelleher M; Bacic A; McConville MJ; Tolson DL; Pearson TW; Handman E
    Mol Biochem Parasitol; 1990 May; 40(2):255-67. PubMed ID: 2362605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of Leishmania major amastigote lipophosphoglycan.
    Moody SF; Handman E; McConville MJ; Bacic A
    J Biol Chem; 1993 Sep; 268(25):18457-66. PubMed ID: 8360147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ricin-resistant mutants of Leishmania major which express modified lipophosphoglycan remain infective for mice.
    Cappai R; Morris L; Aebischer T; Bacic A; Curtis JM; Kelleher M; McLeod KS; Moody SF; Osborn AH; Handman E
    Parasitology; 1994 May; 108 ( Pt 4)():397-405. PubMed ID: 8008453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of Leishmania mexicana lipophosphoglycan.
    Ilg T; Etges R; Overath P; McConville MJ; Thomas-Oates J; Thomas J; Homans SW; Ferguson MA
    J Biol Chem; 1992 Apr; 267(10):6834-40. PubMed ID: 1551890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of lipophosphoglycan from Leishmania major: solubilization and characterization of a (beta 1-3)-galactosyltransferase.
    Ng K; Handman E; Bacic A
    Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):247-55. PubMed ID: 8694771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.
    Späth GF; Epstein L; Leader B; Singer SM; Avila HA; Turco SJ; Beverley SM
    Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9258-63. PubMed ID: 10908670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a macrophage-binding determinant on lipophosphoglycan from Leishmania major promastigotes.
    Kelleher M; Bacic A; Handman E
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):6-10. PubMed ID: 1370357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of lipophosphoglycan from Leishmania donovani: characterization of mannosylphosphate transfer in vitro.
    Carver MA; Turco SJ
    Arch Biochem Biophys; 1992 Jun; 295(2):309-17. PubMed ID: 1586160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotes.
    Kelleher M; Curtis JM; Sacks DL; Handman E; Bacic A
    Mol Biochem Parasitol; 1994 Aug; 66(2):187-200. PubMed ID: 7808469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and antigenicity of the lipophosphoglycan from Leishmania major amastigotes.
    Moody SF; Handman E; Bacic A
    Glycobiology; 1991 Sep; 1(4):419-24. PubMed ID: 1820201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage.
    McConville MJ; Turco SJ; Ferguson MA; Sacks DL
    EMBO J; 1992 Oct; 11(10):3593-600. PubMed ID: 1396559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania chagasi: lipophosphoglycan characterization and binding to the midgut of the sand fly vector Lutzomyia longipalpis.
    Soares RP; Macedo ME; Ropert C; Gontijo NF; Almeida IC; Gazzinelli RT; Pimenta PF; Turco SJ
    Mol Biochem Parasitol; 2002 May; 121(2):213-24. PubMed ID: 12034455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the defect in lipophosphoglycan biosynthesis in a non-pathogenic strain of Leishmania major.
    McConville MJ; Homans SW
    J Biol Chem; 1992 Mar; 267(9):5855-61. PubMed ID: 1532574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions.
    Mahoney AB; Sacks DL; Saraiva E; Modi G; Turco SJ
    Biochemistry; 1999 Aug; 38(31):9813-23. PubMed ID: 10433687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania promastigotes require lipophosphoglycan to actively modulate the fusion properties of phagosomes at an early step of phagocytosis.
    Dermine JF; Scianimanico S; Privé C; Descoteaux A; Desjardins M
    Cell Microbiol; 2000 Apr; 2(2):115-26. PubMed ID: 11207568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.